Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Hideki Goto, MDPhD, Daisuke Hidaka, MD, Satoshi Yamamoto, MD PhD, Koji Hayasaka, Rie Michimata, Ikuko Kagawa, Kana Sunagoya, Hiroaki Iijima, Eiko Hayase, MD, Souichi Shiratori, MD PhD, Kohei Okada, MD PhD, Junichi Sugita, MD PhD, Masahiro Onozawa, MD PhD, Daigo Hashimoto, MD PhD, Kaoru Kahata, MD PhD, Katsuya Fujimoto, MD PhD, Tomoyuki Endo, MD PhD, Chikara Shimizu, MD PhD, Takanori Teshima, MD PhD

Blood (2017) 130 (Supplement 1): 4478.

https://doi.org/10.1182/blood.V130.Suppl_1.4478.4478

Published: 2017

Journal Articles

Long-Term Survival with High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Registry Study from the Japan Society for Hematopoietic Cell Transplantation

Tomohiro Aoki, MD, Ritsuro Suzuki, Yachiyo Kuwatsuka, MDPhD, Shinichi Kako, MD, Katsuya Fujimoto, MD PhD, Jun Taguchi, MD PhD, Tadakazu Kondo, MD PhD, Akiyo Yoshida, MD, Toshiro Ito, MD PhD, Yoshimasa Kamoda, Takahiro Fukuda, MD, Tatsuo Ichinohe, Kengo Takeuchi, MD PhD, Koji Izutsu, Junji Suzumiya

Blood (2014) 124 (21): 2560.

https://doi.org/10.1182/blood.V124.21.2560.2560

Published: 2014

Journal Articles

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Mitsufumi Nishio, MD, PhD, Satoshi Yamamoto, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Toshiya Sakai, MD, PhD, Takeshi Kondo, MD, PhD, Akio Shigematsu, MD, PhD, Junichi Sugita, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, M.D., Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 4544.

https://doi.org/10.1182/blood.V120.21.4544.4544

Published: 2012

Journal Articles

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma

Takashi Ishida, MD, PhD, Michinori Ogura, MD, PhD, Kiyohiko Hatake, Masafumi Taniwaki, MD, PhD, Kiyoshi Ando, MD, PhD, Kensei Tobinai, MD, PhD, Katsuya Fujimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Toshihiro Miyamoto, MD, PhD, Naokuni Uike, MD, PhD, Mitsune Tanimoto, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Kenichi Ishizawa, MD, PhD, Junji Suzumiya, MD, PhD, Hiroshi Inagaki, MD, PhD, Kazuo Tamura, MD, PhD, Shiro Akinaga, PhD, Masao Tomonaga, MD, PhD, Ryuzo Ueda, MD, PhD

Blood (2012) 120 (21): 795.

https://doi.org/10.1182/blood.V120.21.795.795

Published: 2012

Journal Articles

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Hideki Goto, MD, PhD, Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Tomoyuki Endo, MD, PhD, Masato Obara, MD, PhD, Keisuke Yamaguchi, MD, PhD, Yukari Takeda, MD, PhD, Hiroshi Nishihara, MD, PhD, Takao Koike, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2011) 118 (21): 521.

https://doi.org/10.1182/blood.V118.21.521.521

Published: 2011

Journal Articles

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Hiroshi Nishihara, MD., PhD., Lei Wang, PhD., Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Masato Obara, MD, PhD, Shinya Tanaka, MD., PhD.

Blood (2011) 118 (21): 5230.

https://doi.org/10.1182/blood.V118.21.5230.5230

Published: 2011

Journal Articles

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Satoshi Yamamoto, MD, PhD, Toshiya Sakai, MD, Kohki Kumano, MD, Masato Obara, MD, Kazuki Koizumi, MD, PhD, Masaya Mukai, MD, PhD, Norihiro Sato, MD, PhD, Takao Koike, MD, PhD

Blood (2006) 108 (11): 938.

https://doi.org/10.1182/blood.V108.11.938.938

Published: 2006

NARROW

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Email alerts

ASH Publications

American Society of Hematology

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CCR4 Antibody, in Patients with Relapsed Peripheral and Cutaneous T-Cell Lymphoma

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Delayed Redistribution of CD27, CD40 and CD80 Positive B Cells and the Impaired In Vitro Immunoglobulin G Production in Patients with Non-Hodgkin Lymphoma Treated with Rituximab.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only